WBR0185

Revision as of 13:56, 2 September 2014 by Sergekorjian (talk | contribs)
Jump to navigation Jump to search
 
Author [[PageAuthor::Ogheneochuko Ajari, MB.BS, MS [1] (Reviewed by Serge Korjian)]]
Exam Type ExamType::USMLE Step 1
Main Category MainCategory::Genetics, MainCategory::Pathology
Sub Category SubCategory::Oncology
Prompt [[Prompt::An 7-year-old boy is brought by his parents to the emergency department for severe left leg pain that started 2 days prior to presentation. His mother reports that the child has been very tired for the past few weeks. She also explains that he son has lost a lot of weight, and has been running out of breath with minimal activity recently. Upon further questioning, the child denies any trauma to his leg. On physical exam, you notice an ill appearing child with abdominal swelling and petechiae on the upper and lower extremities. A CBC is drawn and shows a Hb of 8.5 g/dL, hematocrit of 25, and a WBC count of 75,000/uL. Which of the following findings is considered a good prognostic marker in this patient?]]
Answer A AnswerA::t(12;21) translocation
Answer A Explanation AnswerAExp::t(12, 21) translocation offers a better or favorable prognosis in ALL and this aids in the selection of therapies for cases of ALL
Answer B AnswerB::t(11;22) translocation
Answer B Explanation AnswerBExp::t(11,22) translocation is associated with Ewing’s sarcoma
Answer C AnswerC::Ten-eleven translocation 2 (TET2)
Answer C Explanation AnswerCExp::Ten-eleven translocation 2 (TET2) is a gene located on chromosome 4q24. Mutations’ involving this gene is found in myeloid malignancies including myelodysplastic syndromes, CML, AML. It is not a prognostic indicator in ALL
Answer D AnswerD::TdT
Answer D Explanation AnswerDExp::TdT is a protein expressed early in the development of pre-T and pre-B cells but it is not a prognostic marker of the disease
Answer E AnswerE::Isocitrate dehydrogenase 1/2 (IDH1/IDH2)
Answer E Explanation [[AnswerEExp::Isocitrate dehydrogenase 1 (IDH1) is a gene located in chromosome 2q33.3 while IDH2 is located in chromosome 15q26.1. These genes are responsible for encoding enzymes catalyzing oxidative decarboxylation of isocitrate to alpha ketoglutarate. Mutations in this gene confer poor prognosis in certain subsets of AML]]
Right Answer RightAnswer::A
Explanation [[Explanation::Acute lymphoblastic leukemia (ALL) is the most common childhood malignancy, accounting for approximately 30% of all cancers in patients younger than 14 years of age. It is a clonal lymphoid stem cell disease.


It could be of the early pre-B-cell leukemia or the T-cell ALL. T(12,21) translocation is the most common structural chromosome change on childhood cancer and is exclusively associated with the B-cell precursor subset of ALL. The translocation generates TEL-AML1 (ETV6-RUNXI) fusion gene, which is associated with a more favorable prognosis as evidenced by a significantly lower relapse rate. Evaluation of this and other prognostic markers helps in selecting low toxicity versus high toxicity therapies

Educational Objective: t(12,21) translocation is a good prognostic marker in cases of ALL
Educational Objective: The t(12,21) translocation is a good prognostic marker in cases of acute lymphoblastic leukemia.
References: ]]

Approved Approved::Yes
Keyword
Linked Question Linked::
Order in Linked Questions LinkedOrder::